DAFNA Capital Management as of Dec. 31, 2019
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 81 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Stereotaxis (STXS) | 24.8 | $72M | 14M | 5.29 | |
Proqr Thrapeutics N V shs euro (PRQR) | 3.8 | $11M | 1.1M | 9.91 | |
AtriCure (ATRC) | 3.6 | $10M | 319k | 32.51 | |
ArQule | 3.4 | $9.9M | 498k | 19.96 | |
Blueprint Medicines (BPMC) | 3.4 | $9.9M | 123k | 80.11 | |
Galapagos Nv- (GLPG) | 3.3 | $9.7M | 47k | 206.83 | |
Fate Therapeutics (FATE) | 3.2 | $9.2M | 470k | 19.57 | |
Sage Therapeutics (SAGE) | 3.1 | $9.0M | 125k | 72.19 | |
Dex (DXCM) | 2.7 | $7.9M | 36k | 218.75 | |
iShares NASDAQ Biotechnology Index (IBB) | 2.7 | $7.8M | 65k | 120.51 | |
Neurocrine Biosciences (NBIX) | 2.2 | $6.6M | 61k | 107.49 | |
Aerie Pharmaceuticals | 2.2 | $6.5M | 268k | 24.17 | |
Zogenix | 1.9 | $5.6M | 107k | 52.13 | |
Cara Therapeutics (CARA) | 1.8 | $5.3M | 329k | 16.11 | |
Akebia Therapeutics (AKBA) | 1.7 | $4.9M | 771k | 6.32 | |
Luminex Corporation | 1.6 | $4.7M | 204k | 23.16 | |
Arena Pharmaceuticals | 1.5 | $4.5M | 99k | 45.42 | |
Cytokinetics (CYTK) | 1.5 | $4.4M | 419k | 10.61 | |
Biohaven Pharmaceutical Holding | 1.4 | $4.1M | 75k | 54.44 | |
Ascendis Pharma A S (ASND) | 1.3 | $3.9M | 28k | 139.11 | |
Menlo Therapeutics | 1.3 | $3.7M | 798k | 4.64 | |
Radius Health Inc note 3.000% 9/0 | 1.2 | $3.4M | 4.0M | 0.85 | |
Xenon Pharmaceuticals (XENE) | 1.1 | $3.3M | 249k | 13.11 | |
Affimed Therapeutics B V | 1.1 | $3.1M | 1.1M | 2.74 | |
Achillion Pharmaceuticals | 0.9 | $2.6M | 439k | 6.03 | |
Dicerna Pharmaceuticals | 0.9 | $2.6M | 118k | 22.03 | |
Biotelemetry | 0.9 | $2.6M | 55k | 46.29 | |
Alector (ALEC) | 0.9 | $2.5M | 145k | 17.23 | |
Kura Oncology (KURA) | 0.8 | $2.4M | 174k | 13.75 | |
Cardiovascular Systems | 0.8 | $2.2M | 46k | 48.59 | |
Bluebird Bio (BLUE) | 0.8 | $2.2M | 26k | 87.76 | |
Phasebio Pharmaceuticals | 0.8 | $2.2M | 361k | 6.11 | |
Accuray Incorporated (ARAY) | 0.7 | $1.9M | 674k | 2.82 | |
Turning Point Therapeutics I | 0.7 | $1.9M | 30k | 62.29 | |
Arcturus Therapeutics Hldg I (ARCT) | 0.7 | $1.9M | 174k | 10.87 | |
Otonomy | 0.6 | $1.8M | 469k | 3.83 | |
BioCryst Pharmaceuticals (BCRX) | 0.6 | $1.8M | 514k | 3.45 | |
Neuronetics (STIM) | 0.6 | $1.8M | 396k | 4.49 | |
Viking Therapeutics (VKTX) | 0.6 | $1.7M | 209k | 8.02 | |
Kadmon Hldgs | 0.6 | $1.7M | 374k | 4.53 | |
Epizyme | 0.6 | $1.7M | 68k | 24.60 | |
Macrogenics (MGNX) | 0.6 | $1.6M | 150k | 10.88 | |
Applied Genetic Technol Corp C | 0.6 | $1.6M | 359k | 4.52 | |
Corbus Pharmaceuticals Hldgs | 0.6 | $1.6M | 297k | 5.46 | |
Inogen (INGN) | 0.5 | $1.6M | 23k | 68.35 | |
Ardelyx (ARDX) | 0.5 | $1.5M | 200k | 7.51 | |
Eloxx Pharmaceuticals | 0.5 | $1.5M | 206k | 7.36 | |
Translate Bio | 0.5 | $1.5M | 180k | 8.14 | |
Natus Medical | 0.5 | $1.4M | 43k | 32.98 | |
Johnson & Johnson (JNJ) | 0.5 | $1.4M | 9.4k | 145.85 | |
Autolus Therapeutics Plc spon ads (AUTL) | 0.5 | $1.3M | 100k | 13.20 | |
Synlogic | 0.4 | $1.3M | 501k | 2.58 | |
Madrigal Pharmaceuticals (MDGL) | 0.4 | $1.2M | 14k | 91.10 | |
Apellis Pharmaceuticals (APLS) | 0.4 | $1.2M | 41k | 30.62 | |
Prevail Therapeutics Ord | 0.4 | $1.2M | 75k | 15.83 | |
Genocea Biosciences (GNCAQ) | 0.4 | $1.1M | 543k | 2.07 | |
Nextcure (NXTC) | 0.4 | $1.1M | 20k | 56.35 | |
Scynexis | 0.4 | $1.1M | 1.2M | 0.91 | |
Argenx Se (ARGX) | 0.3 | $975k | 6.1k | 160.60 | |
Millendo Therapeutics | 0.3 | $873k | 130k | 6.74 | |
Cytomx Therapeutics (CTMX) | 0.3 | $831k | 100k | 8.31 | |
Exicure | 0.3 | $787k | 275k | 2.86 | |
Insmed (INSM) | 0.2 | $716k | 30k | 23.87 | |
Assembly Biosciences | 0.2 | $728k | 36k | 20.46 | |
Gamida Cell | 0.2 | $640k | 149k | 4.30 | |
Morphic Hldg (MORF) | 0.2 | $635k | 37k | 17.16 | |
Mersana Therapeutics (MRSN) | 0.2 | $622k | 109k | 5.73 | |
Dexcom Inc dbcv 0.750% 5/1 | 0.2 | $555k | 250k | 2.22 | |
Masimo Corporation (MASI) | 0.2 | $474k | 3.0k | 158.00 | |
Radius Health | 0.1 | $444k | 22k | 20.18 | |
Kalvista Pharmaceuticals (KALV) | 0.1 | $440k | 25k | 17.80 | |
Gritstone Oncology Ord (GRTS) | 0.1 | $449k | 50k | 8.98 | |
Sutro Biopharma (STRO) | 0.1 | $440k | 40k | 11.00 | |
Rigel Pharmaceuticals | 0.1 | $338k | 158k | 2.14 | |
Zafgen | 0.1 | $339k | 306k | 1.11 | |
Wave Life Sciences (WVE) | 0.1 | $296k | 37k | 8.01 | |
Advaxis | 0.1 | $301k | 350k | 0.86 | |
Aslan Pharmaceuticals Adr ads | 0.1 | $239k | 118k | 2.03 | |
Urogen Pharma (URGN) | 0.1 | $133k | 4.0k | 33.36 | |
Lineage Cell Therapeutics In (LCTX) | 0.0 | $85k | 95k | 0.89 | |
Evelo Biosciences | 0.0 | $44k | 11k | 4.10 |